Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 5860

AtaiBeckley stock drops on Phase 2a data; Disc to refile rare disease drug

$
0
0
Plus, news about Boehringer Ingelheim, Sitryx Therapeutics, Argenx, Palvella Therapeutics, Vir Biotechnology, Larimar Therapeutics, Bristol Myers Squibb and SystImmune: 📉 AtaiBeckley releases Phase 2a data, stock falls: The company

Viewing all articles
Browse latest Browse all 5860

Trending Articles